The closures are part of the retail pharmacy giant’s “transformational cost management program,” in which it expects to save $1.5 billion in annual expenses by fiscal year 2022.
Walgreens expects to take a $1.9 billion to $2.4 billion earnings hit from the closures, including costs related to real estate and severance.
The move comes after its parent company Walgreens Boots Alliance earlier this year announced plans to close 200 stores in the U.K.
Its rival CVS also said it would close 46 underperforming stores in May and in June CVS warned it will close more stores as leases come up for renewal.
More articles on pharmacy:
Average chief pharmacy officer salary by state
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
Colombia fines Pfizer $25K for drug price inflation
